RIGEL PHARMACEUTICALS INC (RIGL)
Clinical trial NCT07704658: start date: 2026-06-01 → 2026-03-04.
Clinical trial NCT07704658: start date: 2026-06-01 → 2026-03-04.
Clinical trial NCT06880549: status: ACTIVE_NOT_RECRUITING → RECRUITING.
Clinical trial NCT05818098 updates: 1. status: UNKNOWN → COMPLETED 2. completion date: 2024-03-01 → 2023-09-15 3. primary completion date: 2023-09-01 → 2023-09-15 4. enrollment type: ESTIMATED → ACTUAL 5. collaborators added: Shengjing Hospital, The People's Hospital of Liaoning Province, Wuhan Central Hospital, Xiamen Cardiovascular Hospital, Xiamen University, Shanxi Bethune Hospital, …
Tri Counties Bank Releases Small Business Cybersecurity Study
Security National Financial Corporation Reports Financial Results For The Quarter Ended June 30, 2026
Papa Johns International Investigation Notice: Levi & Korsinsky Notifies Investors of Pending Investigation Into Papa Johns International (PZZA)
ATS Corporation Investigation Notice: Levi & Korsinsky Notifies Investors of Pending Investigation Into ATS Corporation (ATS)
Celsius Holdings Investigation Notice: Levi & Korsinsky Notifies Investors of Pending Investigation Into Celsius Holdings (CELH)
ThredUp Investigation Notice: Levi & Korsinsky Notifies Investors of Pending Investigation Into ThredUp (TDUP)
Frontdoor, Inc. to Attend and Present at the KeyBanc Technology Leadership Forum